Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Draft toxicological profile for manganese
  • Published Date:
    September 2008
  • Language:
    English
Filetype[PDF-9.61 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Draft toxicological profile for manganese
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Coming Soon
    SUPPLEMENTARY TABLE. Estimated vaccination coverage with selected vaccines and doses* among adolescents aged 13–17 years† (N = 18,788) by HHS region, state, selected local area, or territory — National Immunization Survey–Teen (NIS-Teen), United States, 2019
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    08/21/2020
    Series:
    MMWR. Morbidity and mortality supplementary materials
    Description:
    MMWR Supplementary Table for Volume 69 no.33
    Public Access
    Available on:
    August 18, 2020
  2. Coming Soon
    SUPPLEMENTARY FIGURE 2. HPV* vaccination initiation (>1 dose) and HPV UTD† estimates among adolescents by age 13 years, by birth cohort — National Immunization Survey— Teen (NIS-Teen), United States, 2015-2019
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    08/21/2020
    Series:
    MMWR. Morbidity and mortality supplementary materials
    Description:
    MMWR Supplementary Table for Volume 69 no.33
    Public Access
    Available on:
    August 18, 2020
  3. Coming Soon
    SUPPLEMENTARY FIGURE 1. Weekly provider order comparisons, human papilloma virus (HPV) vaccine (A), tetanus and diphtheria toxoids (TD) and tetanus and diphtheria toxoids and acellular pertussis vaccines (TDAP) vaccines (B), and meningococcal conjugate vaccine (MCV4) (Menveo) vaccine (C) — United States, fiscal years 2019 and 2020
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    08/21/2020
    Series:
    MMWR. Morbidity and mortality supplementary materials
    Description:
    MMWR Supplementary Table for Volume 69 no.33
    Public Access
    Available on:
    August 18, 2020
  4. Sources of Sodium Potassium Supplement
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    08/14/2020
    Series:
    MMWR. Morbidity and mortality supplementary materials
    Description:
    MMWR Supplementary Table for Volume 69 no.32
    File Type:
    Filetype[PDF - 164.51 KB]
  5. Staffing resources : get and keep America open: supporting states, tribes, localities, and territories
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    August 11, 2020
    Description:
    Updated Aug. 11, 2020Strengthening the public health workforce. Enhancing frontline public health capacity in state, local, tribal, and territorial health departments to intensify the coordinated response to COVID-19 is critical.
    File Type:
    Filetype[PDF - 627.64 KB]